CANB610:Inflammation: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
(New page: {{Template:CANB 610 Advanced Topics in Cancer Biology}} ==Discussion Points==) |
Tim Butler (talk | contribs) |
||
| Line 2: | Line 2: | ||
==Discussion Points== | ==Discussion Points== | ||
'''Inflammation-Cancer link, what about long-term anti-inflammatory use?'''<br> | |||
There is a reduced cancer risk for people using non-steroidal anti-inflammatories for management of inflammation <br> | |||
'''Phenotype of OGG1/Muty knockouts?''' <br> | |||
Muty -/- mice have a cancer phenotype, increased intestinal cancers. Not the case for OGG1, reduced cancer. Difference is due to Muty knockouts causing increased transversions <br> | |||
Latest revision as of 18:20, 1 March 2012
Discussion Points
Inflammation-Cancer link, what about long-term anti-inflammatory use?
There is a reduced cancer risk for people using non-steroidal anti-inflammatories for management of inflammation
Phenotype of OGG1/Muty knockouts?
Muty -/- mice have a cancer phenotype, increased intestinal cancers. Not the case for OGG1, reduced cancer. Difference is due to Muty knockouts causing increased transversions
